Ранние неврологические осложнения онкологических заболеваний: полиневропатия и тревожно-депрессивные расстройства.
Механизмы формирования и методы коррекции
Диссертация
Для пациентов со злокачественными новообразованиями, независимо от локализации и гистологического строения опухоли, характерно раннее развитие патологии со стороны периферических нервов (в 73% случаев) с формированием клинико-нейрофизиологического паттерна сенсорно-вегетативной полиневропатии (с заинтересованностью поверхностных видов чувствительности), а также изменение психоэмоциональной сферы… Читать ещё >
Список литературы
- Н. Шкалы, тесты и опросники в медицинской реабилитации. -Москва: Медицина, 2002. 397 с.
- Вшенский Б. С., Виноградов О. И., Кузнецов H.H. Повторное курсовое назначение Церебролизина — новое направление реабилитации больных, перенесших ишемический инсульт // Русский Мед Журнал. -2008. -№ 16(12).-С.1658−1662.
- Войнаревич, А.О. Диагностика и лечение нейротоксических осложнений химиотерапии производными платины у онкологических больных //Вестник РОНЦ им. H.H. Блохина РАМН.-1997.-№ 1 .-С.8−12.
- Гехт Б. М, Касаткина Л. Ф., Самойлов М. И., Санадзе А. Г. Электромиография в диагностике нервно-мышечных заболеваний. — Таганрог: ТРТУ, 1997. 370 с.
- Гехт Б.М. Теоретическая и клиническая электромиография. — Ленинград: Наука, 1990.-230 с.
- Гехт Б.М., Меркулова Д. М. Практические аспекты клиники и лечения полиневропатий // Неврол. Журн. 1997. — № 2. — С. 4−9.
- Гехт Б.М., Меркулова Д. М., Касаткина Л. Ф., Самойлов М. И. Клиника, диагностика и лечение демиелинизирующих полиневропатий // Неврол. Журн. 1996. — № 1. — С. 12−18.
- Гехт Б.М., Меркулова Д. М., Меркулов Ю. А., Головкина О. В. Лечение аксональных и демиелинизирующих полиневропатий // Лечение нервных болезней.-2003.-Т. 4. — № 1. — С. 5−9.
- Голубев В.Л., Вейн A.M. Неврологические синдромы: руководство для врачей Москва: Эйдос Медиа, 2002. — 832 с.
- Гомазков O.A. Плейотропные эффекты нейротрофинов. Принципы терапевтического действия церебролизина. Москва 2010.
- Гусева М.Р., Дубовская JI.A. Эффективность применения препарата Cerebrolysin при заболеваниях зрительного нерва // IV Международный Симпозиум «Церебролизин: фармакологические эффекты и место в клинической практике». Москва. -2002. — С. 129−136.
- Давыдов М.И., Ганцев Ш. Х. Онкология. Учебник. М.: ГЭОТАР — медиа. 2010.
- K.M. Беляков, A.B. Алясова, М. Ю. Кирсанов. Особенности неврологических нарушений у больных с постмастэктомическим синдромом // Российский онкологический журнал. 2007. — № 1. — С13−15.
- K.M. Беляков. Варианты паранеопластических полиневропатий у больных раком молочной железы // Материалы Четвертой Международной научно-практической конференции «Здоровье и образование в XXI веке», Москва. 2003.-С.86−87.
- К.М.Беляков, A.B. Алясова, A.B. Густое. Особенности теченияпаранеопластических полиневропатий у больных раком молочной железы // Десятая конференция «Нейроиммунология»: тезисы докладов, Санкт-Петербург. 2001. — С.24−26.
- И.Команцее В. Н., Заболотных В. А. Методические основы клинической электронейромиографии. Руководство для врачей. Санкт-Петербург. — 2001.-349 с. 23 .Коуэн Ч., Брумлик К. Руководство по электромиографии и электродиагностике. — М.: Медицина, 1975. — 192 с.
- Коштоянц X. С. Белковые тела, обмен веществ и нервная регуляция. Москва: Наука. 1951.
- Крыжаноеский Г. К., Луценко В. К. Значение нейротрофических факторов для патологии центральной нервной системы // Успехи современной биологии. 2006. — № 115(1). — С. 31−48.
- Крыжаноеский Г. Н. Введение в общую патофизиологию. — Москва: РГМУ, 2000.-71 с. 21 .Крыжаноеский Г. Н. Детерминантные структуры в патологии нервной системы. Москва: Медицина, 1980. — 358 с.
- Крыжаноеский Г. Н. Общая патофизиология нервной системы.- Москва: Медицина, 1997. 350 с.
- Кукушкин M.JI. Патофизиологические механизмы болевых синдромов // Боль. 2003 № 1. — С. 12−17
- Левин О.С. Полинейропатии. — Москва: Медицинское информационное агентство, 2005. — 496 с. 31 .Меншикова Е. Б., Панкин В. З., Зенков Н. К. Окислительный стресс. Москва. Слово, 2006.-550 с.
- Ъ2.Реброва О. Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. Москва: МедиаСфера, 2002. -312 с.
- Сафарова Е.Р., Шрам С. И., Гривенников И. А., Мясоедов Н. Ф. Трофические эффекты пептидных препаратов церебролизина и семакса в культуре клеток феохромоцитомы // Бюлл. Эксп. Биол. Мед. 2002. -№ 133(4).-С. 401−3.
- Смулевич А.Б. Депрессии в общемедицинской практике. — Москва: Издание, 2000.- 159 с.
- Шакирова КН. Паранеопластические синдромы // Журнал неврологии и психиатрии им. С. С. Корсакова. 1999.-N 10.-С.55−62
- Шакирова КН., Фокина Н. М. Неврологические осложнения химиотерапии у больных со злокачественными новообрахованиями // Неврологический журнал. 2006. -№ 4 — С.24−28
- ЪЪ.Эсбери А. К., Джиллиатт Р. У. Заболевания периферической нервной системы. Москва: Медицина, 1987. — 352 с.
- Ъ9.Ярыгин ?.H. Тканевые клеточные системы — основа биомедицинских клеточных технологий нового поколения: контуры идеологии // Вестн Рос Акад Мед Наук. 2004. — № 9. — С. 12−19.
- Alters J, Chaudhry V, Cavaletti G, et al: Interventions for preventing neuropathy caused by cisplatin and related compounds // Cochrane Database Syst Rev Jan. 2007. — V 24(1). — P. 128- 131.
- Al-Shekhlee A, Lindenberg JR, Hachwi RN, Chelimsky TC. The value of autonomic testing in postural tachycardia syndrome // Clin Auton Res. 2005. -V 15(3).-P. 219−22.
- Amato A. Chronic inflammatory demyelinating polyneuropathy In: 51 AAN Meeting.-Toronto: Canada, 1999.-P. 123−128.45 .Amato AA, Collins MP. Neuropathies, associated with malignancy// Semin Neurol. 2005. — V. 18 (1). — P. 125−44
- American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) // Neurology. 1991,-V. 41.-P. 617−618.
- Al.Antoine JC, Cinotti L, Tilikete C et al. 18 °F.fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies // Ann Neurol. — 2000. V 48. -P. 105−108.
- Argyriou AA, Chroni E, Kontras A, et al: Preventing paclitaxel-induced peripheral neuropathy: A phase II trial of vitamin E supplementation // J Pain Symptom Manage. 2006. — V. 32(3). — P. 237−244.
- Argyriou AA, Polychronopoulos P, Iconomou G, et al: A review on oxaliplatin-induced peripheral nerve damage // Cancer Treat Rev. 2008. — V. 34(4). — P. 368−377.
- Argyriou AA, Polychronopoulos P, Iconomou G, et al: A review on oxaliplatin-induced peripheral nerve damage. Cancer Treat Rev. — 2008. — V. 34(4). — P. 368−377.
- As bury A. K., Arnason B.G., Adams R.D. The inflammatory lesion in idiopathic polyneuritis//Medicine. 1969.-V. 48.-P. 173−215.
- Asselbergs FW, Kremer Hovinga TK, Bouwsma C, van Ingen J. Acute intermittent porphyria as a cause of respiratory failure: case report // Am J Crit Care. -2009. V- 18(2).-P. 178−9.
- Bassotti G, Villanacci V. Slow transit constipation: a functional disorder becomes an enteric neuropathy // World J Gastroenterol. — 2006. — V. 12(29). — P. 4609−13.
- Becker E, Bonni A. Cell cycle regulation of neuronal apoptosis in development and disease // Progress in Neurobiol. 2004. — V. 72(1). — P. 1−25
- Brady PA, Low PA, Shen WK. Inappropriate sinus tachycardia, postural orthostatic tachycardia syndrome, and overlapping syndromes // Pacing Clin Electrophysiol. 2005. — V. 28(10). P. 1112−21.
- Bramham CR. Control of synaptic consolidation in the dentate gyrus: mechanisms, functions, and therapeutic implication // Progress in Brain Research.-2007.-V. 163.-P. 453−471.
- Camdessanche JP, Antoine JC, HonnoratJ. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients // Brain. Jan. 2002. — V. 125 (Pt 1). -P. 166−75
- I.Candler PM, Hart PE, Barnett M et al. A follow up study of patients with paraneoplastic neurological disease in the United Kingdom // J Neurol NeurosorgPsychiatry. -2004. V. 75 (10).-P. 1411−15
- Candler PM, Hart PE, Barnett M et al. Carcinoma associated paraneoplastic peripheral neuropathy // J Neurol Neurosurg Psychiatry. 2004. — V. 67. — P. 4
- Carrel R. Cell toxicity and conformational disease // Trends Cell Biol. 2005. -V. 15(11).-P. 574−580.
- Castelli L, Binaschi L, Caldera P, Mussa A, Torta R. Fast screening of depression in cancer patients: the effectiveness of the HADS // Eur J Cancer Care (Engl). -2010. -V 12 (3). -P 1123−24.
- Cavaletti G, Zanna C: Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity // Eur J Cancer. 2002. — V. 38(14).-P. 1832−1837.
- Chen H et ah Trophic factors counteract elevated FGF 2 — induced inhibition of adult neurogenesis // Neurobiology of Aging. — 2007. — V. 28. — P. 1148−62.
- Darnell RB. Paraneoplastic neurologic disorders: windows into neuronal function and tumor immunity // Arch Neurol. 2004. — V. 61(1). — P. 30−2.
- Darnell RB. The importance of defining the paraneoplastic neurologic disorders //N Engl J Med. — 1999. — V. 340(23).-P. 1831−3.81 .Dawbarn D, Allen SJ. Neurotrophins and neurodegeneration 11 Neuropath Appl Neurobiol. 2003. — V. 29(3). — P. 211−230.
- Denny Drown D. Primary sensory neuropathy with muscular changes associated with carcinoma //J Neurol Neurosurg Psychiatr. — 1948. — V. 11. — P. 73−87
- Dougherty PM, Cata JP, Burton AW, et al: Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain // J Pain Symptom Manage. 2007. — V. 33(2).-P. 166−179.
- Finnerup NB. Is duloxetine useful for central neuropathic pain? J Pain Symptom Manage. 2008. — V. 62(3). — P. 113−117.
- Freeman R. Autonomic peripheral neuropathy // Neurologic clinics. 2007. -V. 25(1).-P. 23−25
- Freeman R. Current pharmacologic treatment for orthosthtatic hypotension // Clin Auton Res. 2008. — V. 18(1).-P. 14−8
- Gandhi L, Johnson BE. Paraneoplastic syndromes associated with small cell lung cancer // J Natl Compr Cane Netw. 2006. — V. 4(6). — P. 631−8.
- Gedlicka C, Scheithauer W, SchullB, KornekGV. Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid // J Clin Oncol. 2002. — V. 20(15).-P. 3359−61.
- Gomber S, Dewan P, Chhonker D. Vincristine induced neurotoxicity in cancer patients // Indian J Pediatr. 2010. — V. 77(1). — P. 97−100.
- Gomez Palacio — Schjetnan, Escobar ML. In vivo BDNF modulation of adult functional and morphological synaptic plasticity at hippocampal mossy fibers // Neurosci.Lett. — 2008. — V. 445. — P. 62−67.
- Graus F, Keime — GuibertF, Rene R, Benyahia B, Ribalta T, Ascaso C, et al. Anti-Hu associated paraneoplastic encephalomyelitis // Brain. 2001. — V. 124. -P. 1138−48
- Graus F, Keime — Guibert F, Rene R. Carcinoma associated paraneoplastic peripheral neuropathy // J Neurol Neurosurg Psychiatry. 1999. — V. 67. — P. 4
- Grubb BP. Neurocardiogenic syncope and related disorders of orthosthatic intolerance // Circulation. 2005. — V. 111 (22). — P. 2997−3006
- Hausheer FH, Schilsky RL, Bain S, et al: Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy // Semin Oncol. -2006.-V. 33(1).-P. 15−49.
- Henderson RD, Pandian JD, Dalton KM, Bradfield JM. Autonomic neuropathy an uncommon variant of Guillain-Barre syndrome // Med. -2010.-V. 192(4).-P. 232.
- Horwich MS, Cho L, Porro RS et al. Subacute sensory neuropathy: aremote effect of carcinoma // Ann Neurol. 1977. — V.2. — P. 7−19.
- Inuzuka T. Autoantibodies in paraneoplastic neurological syndrome // Am J Med Sci. 2000. — V. 319(4). — P. 217−26.
- Ischiropoulos H, Beckman J. Oxidative stress and nitration in neurodegeneration: cause, effect, or association? // J Clin Invest. 2003. — V. 111(2).-P. 163−169.
- Jemal A, SiegelR, WardE at al. «Cancer statistics. 2008» // CA Cancer J Clin.-2008.-V. 58 (2).-P. 71−96
- Kannarkat G, Lasher EE, Schiff D. Neurologic complications of chemotherapy agents // Curr Opin Neurol. 2007. — V. 20(6). P. 719−725.
- Kempler P. Neuropathies. Pathomechanism, clinical presentation, diagnosis, therapy. Ed. by P. Kemple Springer. — 2002.-208 p.
- Khandoker AH, JelinekHF, Moritani T, Palaniswami M. Association of cardiac autonomic neuropathy with alteration of sympatho-vagal balance through heart rate variability analysis // Med Eng Phys. 2010. V. 32(2). — P. 161−7.
- Klein CM, Vernino S, Lennon VA, Sandroni P, Fealey RDl Benrud-Larson L, Sletten D, Low PA. The spectrum of autoimmune autonomic neuropathies // Ann Neurol. 2003. — V. 53(6). — P. 752−8.
- Klein CM. Evaluation and management of autonomic nervous system disorders // Semin Neurol. 2008. — V. 28(2). — P. 195−204
- Klein CM. Ganglionitis in paraneoplastic subacute sensory neuronopathy: A morphologic study // J Neurol. 1997. — V. 49. — P. 1156−59
- Koutsis G, Spengos K, Panas M, Dimitrakopoulos A, Sfagos C, Vassilopoulos D. Acute painful sensory neuropathy with subclinical autonomic dysfunction as a presenting feature of Hodgkin’s disease // Eur Neurol. — 2005. -V. 53(3).-P. 157−9.
- Kuroi K, Shimozuma K. Neurotoxicity of taxanes: symptoms and quality of life assessment // Breast Cancer. 2004. — V. l 1(1). — P. 92−9.
- Ladumer G, Kalvach P, Moessler H- Cerebrolysin Study Group. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial // J Neural Transm. 2005. — V. 112(3). — P. 41 528. I
- Langkjer ST, Ejlertsen B, Mouridsen H, Andersen J, Nielsen MM, Moller
- KA, Madsen EL, Haarh V- Danish Breast Cancer Co-operative Group. Vinorelbine as first-line or second-line therapy for advanced breast cancer: a Phase I-II trial by the Danish Breast Cancer Co-operative Group. // Acta Oncol. 2008.-V. 47(4).-P. 735−9.
- Levi-Montalcini R. The Nerve growth factor: thirty-five years later // EMBO. J. 1987.-V. 6.-P. 1145−1154.
- Lindner G, Grosse G, Matthies H, Kirsche W. Effects of brain extract and hydrolysate on nerve tissue in vitro // Z Mikrosk Anat Forsch. 1975. — V. 89(5).-P. 815−823.
- Low P.A., Vernino S, Suarez G. Autonomic disfunction in peripheral nerve disease // Muscle Nerve. 2003. — V. 27 (6). — P. 646−61
- Low PA. Prevalence of orthostatic hypotension // Clin Auton Res. 2008. -V. 18(1).-P. 8−13.
- Lu B. BDNF and and activity — dependant synaptic modulation // Learn Mem.-2003.-V. 10.-P. 86−98.
- Malik B, Stillman M: Chemotherapy-induced peripheral neuropathy // Curr Pain Headache Rep/ 2008. — V. 12(3). — P. 165−174.
- Mao L, Wang JQ. Adult neural stem/progenitor cells in neurodegenerative repair // Sheng Li Xue Bao. 2003. — V. 55(3). — P. 233−44.
- Mattson MP, Maudsley S, Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders // Nrends Neurosci. 2004. — V. 27. — P. 589−594.
- McWhinney SR, Goldberg RM, McLeod HL: Platinum neurotoxicity pharmacogenetics // Mol Cancer Ther. 2009. — V. 8(1). — P. 10−16.
- Molinuevo JL, Graus F, Serrano C et al. Utility of anti-Hu antibodies // Support Care Cancer. 2006, V. 36(4). — P. 875−876.
- Mystakidou K, Parpa E, Tsilika E, Gogou P, Panagiotou I, Galanos A, Kouvaris I, Gouliamos A. Self-efficacy, depression, and physical distress in males and females with cancer // Am J Hosp Palliat Care. — 2010. V. 27(8). — P. 518−25.
- Nardone R, Buratti T, Golaszewski S, Bratti A, Caleri F, Tezzon F, Ladurner G, Mitterer M. Delayed oxaliplatin-induced sensorimotor polyneuropathy // Onkologie. 2009. — V. 32(5). — P. 283−5.
- Nurgalieva Z, Xia R, Liu CC, et al: Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer // Am J The. 2009. — V.26(l). — P.974−78.
- O 'Callaghan JP, Sriram K, Miller DB. Defining «neuroinflammation» //Ann NY Acad Sci. 2008. — V. 1139. — P. 318−30.
- Ocean AJ, Vahdat LT: Chemotherapy-induced peripheral neuropathy: Pathogenesis and emerging therapies // Support Care Cancer. 2004. — V. 12(9).-P. 619−625.
- Omerbegovic M. Analysis of heart rate variability and clinical implications // Med Arh. 2009. — V. 63(2). — P. 102−5.
- Ostenfeld T, Tai YT, Martin P, et al. Neurospheres modified to produce glial cell line — derived neurotrophic factor increase the survival of transplanted dopamine neurons // J Neurosci Res. 2002. — V. 69 (6). — P. 955−965
- Park SB, Krishnan AV, Lin CS, et al: Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies I I Curr Med Chem. 2008. — V. 15(29). — P. 3081−3094.
- Pascual AM, Coret F, Casanova B, Lainez MJ. Anterior lumbosacral polyradiculopathy after intrathecal administration of methotrexate // J Neurol Sci. — 2008. V. 15.-P. 158−61
- Peltier AC, Russell JW. Advances in understanding drug-induced neuropathies // Drug Saf. 2006. — V. 29(1). — P. 23−30.
- PittockSJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome // Ann Neurol. — 2004. — V. 56(5). — P. 715−9.
- Polomano RC, Bennett GJ: Chemotherapy-evoked painful peripheral neuropathy I I Pain Med. 2001. — V 2(1). — P.8−14.
- Posner JB. Paraneoplastic syndromes. In: Posner JB, ed., Neurologic Complications of Cancer. Philadelphia: FA Davis. 1995. — P. 353−385.
- Postma T, Hoekman K, van Riel JM, et al Peripheral neuropathy due to biweekly paclitaxel, epirubicin and cisplatin in patients with advanced ovarian cancer//J Neurooncol. 1999. -V. 45. — P. 241−246.
- Price R et al Advances in small molecules promoting neurotrophic function. // Pharm Therap. 2007. — V. 115(2). — P. 292−306.
- Rees JH, Hain SF, Johnson MR et al. The role of 18 °F.fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders // Brain. 2001. — V. 124. — P. 2223−2231.
- Reimer T, Gerber B. Quality-of-life considerations in the treatment of early-stage breast cancer in the elderly // Drugs Aging. — 2010. — V. 27(10). P. 791 800.
- Riley C, Hutter — Paier B, Windisch M, Doppler E, Moessler H, Wronski R. A peptide preparation protects cells in organotypic brain slices against cell death after glutamate intoxication // J Neural Trnsm. 2006. — V. 113 (1). — P. 103−10
- Robertson D. The pathophysiology and diagnosis of orthostatic hypotension // Clin Auton Res. 2008. — V. 18(1). — P. 2−7.
- Royo NC, LeBold D, Magge SN, et al. Neurotrophin mediated neuroprotection of hippocampal neurons following traumatic drain injury is not associated with acute recovery of hippocampal function // Neuroscience. — 2007. — V. 148 (20). — P. 359−370.
- Rudnicki SA, Dalmau J. Paraneoplastic syndromes of the peripheral nerves // Curr Opin Neurol. 2005. — V. 18(5). — P. 598−603.
- Safarova ER, Shram SI, Grivennikov I A, Myasoedov NF. Trophic effects of nootropic peptide preparations cerebrolysin and semax on cultured rat pheochromocytoma // Bull Exp Biol Med. 2002. — V. 133(4). — P. 401−3.
- Saiz A, Blanco Y, Sabater L, Gonzalez F, Bataller L, Casamitjana R, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association // Brain. 2008. -V. 131.-P. 2553−63.
- Scadding J. W. Clinical examination//Handbook of Clinical Neurology/Elsiver, Netherlands., 2006. — V.81. — P.385−395
- Schabitz WR, Hoffmann TT, Heiland S, et al. Delayed neuroprotective effect of insulin — like growth factor — i after experimental transient focal cerebral ischemia monitored with MRI // Stroke. 2001. — V. 32 (5). — P. 1226−1233.
- Schabitz WR, Steigleder T, Cooper — Kuhn CM et al. Intravenous brain derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis // Stroke. 2007. — V. 38 (7). — P. 2165−72
- Schanzer A, Wachs FP, Wilhelm D, et al. Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor // Brain Pathol. 2004. — V. 14(3). — P. 237−248.
- Schauer E, Wronski R, Patockova J, et al. Neuroprotection of cerebrolysin in tissue culture models of brain ischemia post lesion application indicates a wide therapeutic window // J Neural Transm. 2006. — V. 113 (7> — P. 855−868.
- Shams 'ili S, de Beukelaar J, Gratama JW et al. An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes // J Neurol. 2006. — V. 253. — P. 16−20.
- Shilpa Amara. Oral Glutamine for the Prevention of Chemotherapy-Induced Peripheral Neuropathy // The Annals of Pharmacotherapy. 2008. — V. 42(10). -P. 1481−1485.
- Sillevis Smitt P, Grefkens J, De Leeuw B et al. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy // J Neurol. 2002. — V. 249. — P. 745−753.
- Singer S, Brown A, Einenkel J, Hauss J, Hinz A, Klein A, Papsdorf K, Stolzenburg JU, Brahler E. Identifying tumor patients' depression // Support Care Cancer. -2010. -V.54 (2). P. 2236−2237.
- Singer W, Opfer-Gehrking TL, Nickander KK, Hines SM, et.al. Acetylcholinesterase inhibition in patients with orthosthatic intolerance // J Clin Neurophysiol. 2006. — V. 23(5). — P. 476−81
- Singer W, Spies JM, McArthur J, Low J, Griffin JW, Nickander KK, Gordon V, Low PA. Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies // Neurology. — 2004. V. 62(4). P. 612−8.
- Sodhi M, James K Stoller. Small Cell Carcinoma with Paraneoplastic Polyneuropathy and tumor embolization // Respiration. — 2010. V. 79 (1). — P. 963−964.
- Sommer C, Lauria G. Painful small-fiber neuropathies/ZHandbook of Clinical neurology/Elsiver, Netherlands. 2006. — V. 81. — P. 621−33
- Spies JM, McArthur J. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone // J Neur Neurosorg Psychiatry. -2000.-V. 68.-P. 479−82
- StubblefieldM.D., VahdatL.T., Balmaceda C.M. et al. Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic study // Clin Oncol (R Coll Radiol). — 2005. — V. 17(4).-P. 271−276.
- Swain SM, Arezzo JC. Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management //Clin Adv Hematol Oncol. 2008. V. 6(6).-P. 455−67.
- Sztajzel J. Heart rate variability: a noninvasive electrocardiographic method to measure the autonomic nervous system // Swiss Med Wkly. 2004. — V. 134.-P. 514−22.
- Tavee J, Zhou L. Small fiber neuropathy: A burning problem // Cleve Clin J Med. 2009. — V.76(5). — P. 297−305.
- Thieben MJ, Sandroni P, Sletten DM, Benrud — Larson LM, et.al. Postural orthostatic tachycardia syndrome: the Mayo clinic experience // Mayo Clin Proc. 2007. — V. 82 (3).-P. 308−13
- Torer N, Nursal TZ, Caligkan K, Ezer A, Colakoglu T, Moray G, Haberal M. The effect of the psychological status of breast cancer patients on the short-term clinical outcome after mastectomy //Acta Chir Belg. 2010. — V. 110(4). — P. 467−70.
- Vernino S, Lennon VA. New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity // Ann Neurol. — 2000. — V. 47. — P. 297−305.
- Vernino S, Low PA, Fealey RD. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies // N Engl J Med. 2000. — V. 343 (12).-P. 847−55
- Visovsky C, Daly B. Clinical evaluation and patterns of chemotherapy-induced peripheral neuropathy // J Am Acad Nurse Prac. 2004. — V. 16. P. 353−359.
- Wilkes G: Peripheral neuropathy related to chemotherapy // Semin’Oncol. -2007.-23(3).-P. 162−173.
- Wilkinson PC, Zeromski J. Immunofluorescent detection of antibodies against neurones in sensory carcinomatous neuropathy // Brain. 1965. — V. 88(3).-P. 529−83.
- Windisch M, Gschanes A, Hutter — Paier B. Neurotrophic activities and therapeutic experience with a brain derived peptide preparation // J Neural Transm Suppl. 1998. — V. 53. — P. 289−298.
- Wolf S, Barton D, Kottschade L, et al: Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies // Eur J Cancer. 2008. — V. 44(11).-P. 1507−1515.
- Wood MJ, Molassiotis A, Payne S. What research evidence is there for the use of art therapy in the management of symptoms in adults with cancer? A systematic review // Psychooncology. — 2010, V. 3. — P.25−26.
- Younes-Mhenni S, Janier MF, Cinotti L et al. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes // Brain. -2004.-V. 127.-P. 2331−2338.